Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |